Posted inCovid-19

Glaxo, SK bioscience start final trial of vaccine

British drugs giant GlaxoSmithKline and South Korean peer SK bioscience have started final stage trials of a Covid-19 jab after positive early results, they announced Tuesday. The vaccine is facing a Phase 3 clinical trial to assess its “safety and immunogenicity” when compared with AstraZeneca’s Covid vaccine, the two companies said in a joint statement. […]

Sign In

We've recently sent you an authentication link. Please, check your inbox!

Sign in with a password below, or sign in using your email.

Get a code sent to your email to sign in, or sign in using a password.

Enter the code you received via email to sign in, or sign in using a password.

Subscribe to our newsletters:

OR
%d bloggers like this: